Familywise error control in multi-armed response-adaptive two-stage designs

Journal of Biopharmaceutical Statistics

Volumn 21, Issue 4, 2011, Pages 818-830

  Gutjahr, Georg ^a   Posch, Martin ^b   Brannath, Werner ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Closed testing; Conditional invariance principle; Nuisance parameters; Response adaptive randomization; Treatment selection

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CALCULATION; CLINICAL TRIAL (TOPIC); COMPUTERIZED ADAPTIVE TESTING; CONTROL STRATEGY; FAMILYWISE ERROR RATE; MATHEMATICAL AND STATISTICAL PROCEDURES; NULL HYPOTHESIS; OUTCOME VARIABLE; PRIORITY JOURNAL; RANDOMIZATION; SAMPLE SIZE; SAMPLING; SIMULATION; STATISTICAL PARAMETERS; STUDY DESIGN; TREATMENT OUTCOME; VALIDATION PROCESS; VARIANCE;

COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; MODELS, STATISTICAL; PROBABILITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 79957472895     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543406.2011.551337     Document Type: Article

References (25)

1. Atkinson, A., Biswas, A. (2009). Response-Adaptive Designs in Clinical Trials. Boca Raton, Florida: Chapman & Hall.
2. Berger, J., Bernardo, J., Sun, D. (2009). The formal definition of reference priors. Annals of Statistics 37:905-938.
3. Berry, D., Müller, P., Grieve, A., Smith, M., Parke, T., Blazek, R., Mitchard, N., Krams, M. (2001). Adaptive bayesian designs for dose-ranging drug trials. In: Gatsonis, C., Kass, R., Carlin, B., Carriquiry, A., Gelman, A., Verdinelli, I., West, M., eds. Case Studies in Bayesian Statistics V. New York: Springer, pp. 99-181.
4. Brannath, W., Bretz, F. (2010). Shortcuts for locally consonant closed test procedures. Journal of the American Statistical Association 105:660-669.
5. Brannath, W., König, F., Bauer, P. (2007). Multiplicity and flexibility in clinical trials. Pharmaceutical Statistics 6:205-216. (Pubitemid 47455260)
6. Burman, C., Sonesson, C. (2006). Are flexible designs sound? Biometrics 62:664-669.
7. Chen, J., DeMets, D., Lan, G. (2004). Increasing the sample size when the unblinded interim result is promising. Statistics in Medicine 23:1023-1038. (Pubitemid 38477065)
8. Denne, J. (2001). Sample size recalculation using conditional power. Statistics in Medicine 20:2645-2660. (Pubitemid 32834374)
9. European Medicines Agency. (2006). Reflection Paper on Methodological Issues in Confirmatory Clinical Trials with Flexible Design and Analysis Plan. Doc. ref. chmp/ ewp/2459/02
10. Food and Drug Administration. (2010). Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics. Doc. Ref. FDA-2010-D-0090-0002.
11. Friede, T., Henderson, R. (2009). Exploring changes in treatment effects across design stages in adaptive trials. Pharmaceutical Statistics 8:62-72.
12. Gutjahr, G., Brannath, W., Bauer, P. (2010). An approach to the conditional error rate principle with nuisance parameters. Biometrics. Available online at: http://onlinelibrary.wiley.com/doi/10.1111/j.1541-0420.2010.01507.x/ full (last accessed 12 March 2011)
13. Hochberg, Y., Tamhane, A. (1987). Multiple Comparison Procedures. New York: Wiley.
14. Hu, F., Rosenberger, W. (2000). Analysis of time trends in adaptive designs with application to a neurophysiology experiment. Statistics in Medicine 19:2067-2075. (Pubitemid 30670523)
15. Hu, F., Rosenberger, W. (2006). The Theory of Response-Adaptive Randomization in Clinical Trials. New York: Wiley.
16. Huang, X., Biswas, S., Oki, Y., Issa, J., Berry, D. (2007). A parallel phase I/II clinical trial design for combination therapies. Biometrics 63:429-436.
17. Marcus, R., Peritz, E., Gabriel, K. (1976). On closed testing procedures with special reference to ordered analysis of variance. Biometrika 63:655-660.
18. Müller, H., Schäfer, H. (2001). Adaptive group sequential designs for clinical trials: Combining the advantages of adaptive and of classical group sequential approaches. Biometrics 57:886-891. (Pubitemid 32801186)
19. Müller, H., Schäfer, H. (2004). A general statistical principle for changing a design any time during the course of a trial. Statistics in Medicine 23:2497-2508. (Pubitemid 39149263)
20. Posch, M., Bauer, P., Brannath, W. (2003). Issues in designing flexible trials. Statistics in Medicine 22:953-969. (Pubitemid 36322097)
21. Posch, M., Maurer, W., Bretz, F. (2010). Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim. Pharmaceutical Statistics. Available online at: http://onlinelibrary. wiley.com/doi/10.1002/pst.413/full(last accessed 12 March 2011)
22. Posch, M., Timmesfeld, N., König, F., Müller, H. (2004). Conditional rejection probabilities of student's t-test and design adaptations. Biometrical Journal 46:389-403. (Pubitemid 41449100)
23. Skrivanek, Z. (2008). A seamless 2/3 design incorporating a clinical utility index. Presented at the FDA/Industry Statistics Workshop, Washington D.C.
24. Timmesfeld, N., Schäfer, H., Müller, H. (2007). Increasing the sample size during clinical trials with t-distributed test statistics without inflating the type I error rate. Statistics in Medicine 26:2449-2464. (Pubitemid 46784204)
25. Wassmer, G. (1998). A comparison of two methods for adaptive interim analyses in clinical trials. Biometrics 54:696-705. (Pubitemid 28262490)